An audit of breast cancer pathology reporting in Australia in 1995 by Kricker, A et al.
The pathologist’s role in breast cancer management is to make a
diagnosis and report key items of information essential to treat-
ment planning. To increase national uniformity in procedures and
reporting, the Australian Cancer Network’s (ACN) Pathology
Working Party released specific recommendations about
pathology reporting of breast cancer specimens in 1997 (ACN
Pathology Working Party, 1997). These recommendations were
that all microscopic reports of invasive breast cancer should
contain information on tumour type, size, grade, margins of
excision, vessel invasion and changes in adjacent breast tissue. For
each case of pure ductal carcinoma in situ (DCIS), recommenda-
tions were to report tumour size, nuclear grade, necrosis, architec-
ture and calcification and, in addition, a clear statement about the
margins of excision.
The NHMRC National Breast Cancer Center (NBCC) under-
took an audit of pathology reporting of breast cancer cases
diagnosed in Australia in 1995, before the release of the recom-
mendations, to measure a baseline for the coverage and complete-
ness of reporting by pathologists in Australia of key items in the
ACN Working Party’s recommendations (ACN Pathology
Working Party, 1997).
MATERIALS AND METHODS
We obtained copies of pathology reports, identified by number
only, from Australian state and territory cancer registries for cases
of invasive breast cancer or DCIS diagnosed in April and May
1995 (and June in the smallest states and territories). In one State,
only three of six laboratories agreed to participate, supplying 57%
of the cases expected in that State.
Completeness of reporting of invasive breast cancer was exam-
ined for the key items: tumour size, histological type, histological
grade, margins of excision, vessel invasion and changes in the
adjacent breast tissue. We examined reporting of changes in adja-
cent breast tissue in two separate items, the presence or absence of
DCIS and changes in adjacent non-neoplastic tissue. In addition,
we examined the reporting of nodal status of all breast cancers and
the presence or absence of an extensive intraductal component
(EIC) associated with infiltrating ductal carcinomas nitric oxide
synthase (NOS) (no special type).
Reports were classified by the type of diagnostic or therapeutic
procedure from which the specimen came. Analyses were based
on reports from biopsies and mastectomies which contained
information about the breast cancer and excluded fine needle
aspirations (FNA), core biopsies and slide reviews.
Completeness was defined as the percentage of reports in which
a definite statement about an item, either positive or negative, was
made. A data dictionary and coding manual and data collection
forms were developed for use by three pathology registrars who
were the auditors. Typically, the data form sought to classify each
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Summary To measure the quality of pathology reporting of breast cancer and establish a baseline against which future changes can be
measured, we audited item completeness in breast cancer reports in Australia in 1995 before the release of specific recommendations from
the Australian Cancer Network. Tumour type and size were given in reports of invasive breast cancer for 93% of women, 70% had, in addition,
grade and clearance of the margins while only 28% had all recommended information. The most complete items in reports were histological
type of breast cancer (99.6% of cases), tumour size (94%, 95% confidence interval (CI) 92–95) and margins of excision (87%, 95% CI
85–89). Histological grade (84%, 95% CI 82–86 of cases) and presence or absence of ductal carcinoma in situ (DCIS) (79%, 95% CI 77–81)
were less complete and vessel invasion (61%, 95% CI 58–63) and changes in non-neoplastic breast tissue adjacent to the breast cancer
(68%, 95% CI 66–71) the least complete. Less than half the reports of DCIS reported on tumour size (49%, 95% CI 42–57), presence or
absence of necrosis (41%, 95% CI 34–49) or nuclear grade (39%, 95% CI 31–46). Around 1500 reports were identified as issued by 147
laboratories and 392 pathologists; 69% of pathologists issued fewer than two reports a month in the audit. We concluded that infrequency of
reporting may have contributed to incompleteness of reporting. In addition, we found significant variation across Australian states with some
indication that reporting was consistently poor in one state. The audit highlighted areas for improvement for breast cancer reporting in
Australia. Research evidence suggests that multifaceted strategies are needed to assist practitioners with implementing more uniform
reporting standards.
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absent or not mentioned. In addition, the grade of a tumour and
actual measurements of size or margins were noted when given.
One data collection form was completed for each pathology report
and there were separate forms for invasive breast cancer and
DCIS. The sample size (1600) was chosen to give completeness
percentages that had 95% confidence bounds that were not more
than 5% on either side of the point estimate.
The extent of agreement among auditors was examined in a
sample of 10% of pathology reports that were audited indepen-
dently by all auditors. The kappa statistic was used to examine
variation between pairs of auditors after adjustment for the extent
of agreement that would be expected by chance (Cohen, 1960).
Three sets of analyses were undertaken which addressed all
reports for each woman, all reports from biopsies and mastec-
tomies and the effects of reporting ‘volume’ on completeness. For
each woman with invasive breast cancer, an item was regarded as
complete if the biopsy or mastectomy report gave the relevant
information. It is possible that the sets of reports available for
some women were incomplete sets. Analyses by reporting
‘volume’ were based on the numbers of reports issued by each
laboratory or pathologist in April and May 1995.
Ninety-five per cent confidence intervals (CI) were calculated
for percentages of complete items using the Normal distribution
for numbers of ten or more and exact limits using the F distribution
for smaller numbers (Armitage and Berry, 1991). Homogeneity
of proportions was tested using the c2 distribution and trends
in percentages across ordered groups were assessed by the
Mantel–Haenszel test for trend (Armitage and Berry, 1991).
RESULTS
We examined 1563 pathology reports of invasive breast cancer
from biopsies and mastectomies for 1409 women diagnosed
with breast cancer in all Australian states and territories in 1995. A
total of 195 reports of re-excision specimens which showed no
residual cancer were excluded. More than half (56%) the women
had only one report, 37% had two reports and 7% had three or
more.
Agreement between the auditors
Auditor 1 completed data collection forms for 879 (34%)
pathology reports of invasive breast cancer, Auditor 2 completed
1312 (50%) and Auditor 3 completed 399 (15%). Agreement was
calculated in 140 pathology reports examined by both Auditors
1 and 2 and 38 reports audited by all three.
The observed agreement between pairs of auditors in classifying
completeness was very high for tumour type, size, grade and
vessel invasion (89% or more) and lower for clearance of the
margins of excision, the presence or absence of DCIS and changes
in adjacent non-neoplastic tissue (between 66% and 88%). The
values of kappa were slightly lower than the observed percentages
of agreement.
Reports of invasive cancer for each woman
Completeness of reporting invasive cancer for each woman was
highest for histological type of cancer (99.6% of cases), tumour
size (94%, 95% CI 92–95) and margins of excision (87%, 95% CI
85–89). Histological grade (84%, 95% CI 82–86 of cases) and
presence or absence of DCIS (79%, 95% CI 77–81) were reported
less while vessel invasion and changes in non-neoplastic breast
tissue adjacent to the breast cancer were reported for fewer than
70% of women. Tumour type and size were both stated in 93% of
reports and 70% of reports had, in addition, grade and clearance of
the margins. Only 28% of all women had all key items reported
(Figure 1).
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Figure 1 Percentage of women with invasive breast cancer for whom
pathology reports from biopsies and mastectomies gave complete
information on key items
Table 1 Completeness of key items in 1563 reports of invasive breast cancer from biopsies and mastectomies with variation in rates across Australian states
Completeness of reports by state of residence
Key item All reports1 State 1 State 2 State 3 State 4 State 5 c2 (P-value)
% (Cl) % (Cl) % (Cl) % (Cl) % (Cl) % (Cl)
Tumour size 89 (87–90) 87 (84–90) 93 (91–96) 86 (82–90) 91 (86–95) 87 (76–94) 14.0 (= 0.02)
Tumour type 99 (99–100) 100 (99–100) 100 (99–100) 99 (99–100) 97 (93–99) 100 (95–100) 17.8 (= 0.003)
Histological grade 80 (78–82) 80 (77–83) 85 (82–89) 74 (69–79) 85 (79–91) 74 (63–84) 18.2 (= 0.003)
Margins of excision 83 (81–85) 84 (81–87) 82 (78–86) 78 (73–83) 86 (81–92) 84 (75–93) 7.5 (= 0.2)
Vessel invasion 57 (55–60) 54 (50–59) 56 (51–60) 54 (47–60) 72 (65–80) 60 (49–72) 17.2 (= 0.004)
Presence of DCIS 75 (73–78) 75 (72–79) 74 (70–78) 72 (66–77) 80 (74–87) 84 (75–93) 8.5 (= 0.1)
Changes in adjacent 61 (58–63) 61 (57–65) 65 (60–69) 49 (43–55) 60 (52–68) 66 (55–77) 19.9 (= 0.001)
non-neoplastic tissue
1All reports irrespective of procedure type. Chi-square test for homogeneity across five Australian states (NSW & ACT, Victoria, Queensland, WA, Tasmania)
with 4 degrees of freedom. CI, confidence interval; DCIS, ductal carcinoma in situ.Reports of invasive breast cancers from biopsies and
mastectomies
Item completeness was examined in greater detail in the 1563
individual reports of invasive breast cancer from biopsies and
mastectomies. Of these, 21% gave a definite finding for all key
items, 51% had six or seven, and 73% had five or less items
complete. As might be expected, less complete information was
given in reports which followed a re-excision, especially tumour
size (23 percentage points less) and histological grade (22
percentage points less), but also vessel invasion and presence of
additional DCIS (10 percentage points less). Reporting of tumour
size was high (89%, 95% CI 87–90), and higher (91%, 95% CI
90–93) when there were one or two tumours than when there were
three or more (65%, 95% CI 57–73%).
Histological grade was given in the majority (80%, 95% CI
78–82) of reports. Overall, 31% of reports named the Bloom and
Richardson grading system, as recommended by the ACN Working
Party. Reports with breast cancer size more often gave grade (85%
of 1175 reports) than those without (45% of 173). Grade was given
less often (33% of 42 reports) for smaller (< 4 mm) than larger
(4 mm or more) cancers (85% of 1348 reports).
Given the importance of clear margins for prognosis and treat-
ment decision, reporting was surprisingly variable. Comments
about excision margins were made in 83% (95% CI 81–85) of
reports but only in 62% (95% CI 59–65) of 1038 reports with clear
margins was a measurement of the margin given. Moreover, the
auditors indicated that, for 33 of 121 reports (27%, 95% CI 19–35)
with a stated margin of 1 mm or less, clearance was, in fact,
uncertain.
There was statistically significant variation (P < 0.05) by
Australian state in completeness of reporting of histological type
and grade, size, vessel invasion and changes in adjacent breast
tissue (Table 1). Differences in reporting histological type were
based on a handful of cases only, while tumour size varied by
seven percentage points, histological grade by eleven, changes in
adjacent non-neoplastic tissue by 17, and vessel invasion by 18
percentage points. One Australian state had the lowest item
completeness in all items (Table 1).
Completeness of reports of tumour size increased significantly
(P < 0.001) with increasing age of the women, from 85% at
< 50 years of age to 93% at 70+ years of age, while there was
significantly (P < 0.001) less complete reporting of DCIS in
women 70+ years (69%) compared with women younger than
70 years (77–78%).
The Pathology Working Party defined an extensive intraductal
component (EIC) principally as the presence of ‘a significant
amount’ of DCIS in an infiltrating ductal cancer NOS, together
with any DCIS in the adjacent breast tissue, noting that there has
been confusion about its definition. Few of the 1199 reports of
infiltrating ductal carcinomas made comments about EIC status.
Thirty-nine per cent described a DCIS component in or adjacent to
the invasive breast cancer as ‘less than or greater than 25%’, ‘EIC+
or EIC–’, or ‘extensive, minimal, or moderate’. Six per cent
measured the extent of DCIS but did not indicate its EIC status,
20% indicated only that DCIS was present or absent and 35% of
reports did not mention DCIS at all.
A statement about lymph nodes was given in 55% (95% CI
52–57) of reports. Most reports mentioning lymph nodes gave the
number of nodes examined (97%) and the number positive (98%;
835 of 852 reports).
Different histological types of invasive breast cancers
Grade was given for 91% (95% CI 89–93) of infiltrating ductal
carcinomas NOS compared with only 34% (95% CI 27–41) of
lobular carcinomas (Table 2). Tumour size (90%, 95% CI 88–92)
and presence or absence of DCIS (82%, 95% CI 80–84) were most
often given for infiltrating ductal carcinomas NOS and least often
for lobular carcinomas (tumour size, 82%, 95% CI 76–87; state-
ments about DCIS, 35%, 95% CI 28–42).
Grade was given for most (96%, 95% CI 95–98) of the infil-
trating ductal carcinomas NOS 3+ mm but only in 35% (95%
CI 15–54) of the cancers less than 3 mm. Infiltrating ductal carci-
nomas NOS with no tumour size had been graded less often (54%,
95% CI 45–63) than reports with size recorded (95%,
95% CI 94–96).
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Table 2 Reporting of key items in reports of invasive breast cancer from biopsies and mastectomies by categories of
histological type
Histological types
Ductal Ductal Lobular Other and
carcinoma of carcinoma of carcinoma unknown type
no special type special types of carcinoma1
(n = 1199) (n = 103) (n = 181) (n = 80)
Key item % (CI) % (CI) % (CI) % (CI)
Tumour size 90 (88–92) 96 (92–100) 82 (76–87) 83 (74–91)
Histological type 100 (100–100) 100 (100–100) 100 (100–100) 90 (83–97)
Histological grade 91 (89–93) 50 (41–60) 34 (27–41) 60 (49–71)
Margins of excision 84 (82–86) 83 (75–90) 79 (73–85) 76 (67–86)
Vessel invasion 61 (58–64) 49 (39–58) 43 (36–50) 432 (32–53)
Presence of DCIS 82 (80–84) 77 (69–85) 35 (28–42) 633 (52–73)
Changes in adjacent 61 (58–64) 64 (55–73) 59 (51–66) 59 (48–70)
non-neoplastic tissue
1Includes carcinomas of mixed type (63 reports), other type (nine reports) and unknown type (eight reports). 2A total of 51%
(95% CI 38–63) in other carcinoma of mixed type. 3A total of 71% (95% CI 59–81) in other carcinoma of mixed type.
CI, confidence interval; DCIS, ductal carcinoma in situ.DCIS
Item completeness for DCIS was measured in 170 reports from
biopsies and mastectomies in 145 women (Table 3). Information
was most complete (95%, 95% CI 91–98) for architecture: 47%
were classified by growth pattern as comedo or solid, cribriform or
micropapillary, 33% were said to be mixed type and 15% were no
special type. Less complete information was given for excision
margins (76%, 95% CI 69–82), tumour size when only one or two
tumours were present (64%, 95% CI 56–71) and calcification
(57%, 95% CI 50–65). Overall less than half the reports gave
tumour size (49%), presence or absence of necrosis (41%) or
nuclear grade (39%).
Completeness of reports of invasive breast cancer by
number of reports for pathologists and laboratories
There were 1316 reports in April and May assigned to categories
of reporting volume; the pathologist was unknown for an addi-
tional 46 cases. Nearly half the pathologists (47%) had issued only
one (29%) or two (18%) reports. The majority (69%) of patholo-
gists issued less than five reports of invasive breast cancer during
these 2 months.
Only vessel invasion showed some evidence of increasing
completeness with increasing volume of reports. Presence or
absence of vessel invasion was described more often by patholo-
gists who had issued five or more reports (59–61%) than less than
five (44–57%; P-value for trend = 0.05) (Table 4).
Of the 129 laboratories identified with 1362 invasive breast
cancer reports, most (91%) had issued less than 15 reports in total
over the 2-month period while only six had issued 40 or more
reports (an average of five a week). The high volume laboratories
had more complete information on tumour size (P for trend =
0.05), margins of excision and vessel invasion (P for trend < 0.05
in each case) (Table 4).
DISCUSSION
Seventy per cent of women with invasive breast cancer in 1995 in
Australia had pathology reports with complete information on
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Table 3 Completeness of pathology reporting of key items in DCIS reports
from biopsies and mastectomies
Reports
All Biopsies Mastectomies
Key item n = 170 n = 117 n = 53
% (CI) % (CI) % (CI)
Tumour size given 49 (42–57) 57 (48–66) 32 (20–45)
One or two tumours 64 (56–71) 71 (63–79) 47 (34–61)
Three or more or multifocal 36 (29–44) 29 (21–37) 53 (39–66)
Margins of excision 76 (69–82) 79 (71–86) 70 (57–82)
Nuclear grade given 39 (31–46) 43 (34–52) 30 (18–43)
Necrosis given 41 (34–49) 42 (33–51) 40 (26–53)
Architecture given 95 (91–98) 93 (89–98) 98 (94–100)
Calcification given 57 (50–64) 67 (58–75) 36 (23–49)
CI, confidence interval.
Table 4 Completeness of key items for invasive breast cancers by categories of pathologists and laboratories
Number of reports issued by pathologists
1–2 3–4 5–6 7–10 10+ Trend1
Key item (n = 244) (n = 265) (n = 238) (n = 341) (n = 228)  c2 (P-value)
% (CI) % (CI) % (CI) % (CI) % (CI)
Tumour size 87 (83–91) 87 (83–91) 88 (84–92) 90 (87–93) 91 (88–95) 3.13 (0.08)
Tumour type 100 (98–100) 99 (97–100) 99 (97–100) 99 (97–100) 100 (98–100) 0.99 (0.61)
Histological grade 80 (74–85) 78 (74–83) 84 (80–89) 79 (75–83) 83 (78–88) 0.62 (0.43)
Excision margins 84 (80–89) 76 (71–81) 88 (84–92) 82 (78–86) 86 (81–90) 1.19 (0.28)
Vessel invasion 57 (51–63) 44 (38–50) 61 (55–68) 59 (54–64) 59 (52–65) 3.96 (0.05)
Presence of DCIS 77 (72–83) 72 (67–78) 76 (71–82) 78 (73–82) 70 (64–76) 0.86 (0.36)
Changes in 64 (58–70) 59 (53–65) 58 (52–64) 59 (53–64) 60 (53–66) 1.07 (0.30)
adjacent non-neoplastic
tissue
Number of reports issued by laboratories
1–6 7–13 14–25 26–40 40+ Trend1
(n = 247) (n = 263) (n = 270) (n = 260) (n = 320)  c2 (P-value)
% (CI) % (CI) % (CI) % (CI) % (CI)
Tumour size 88 (84–92) 88 (84–92) 85 (81–89) 88 (84–92) 94 (91–96) 3.95 (0.05)
Tumour type 100 (98–100) 99 (97–100) 100 (99–100) 100 (99–100) 99 (97–100) 0.99 (0.61)
Histological grade 82 (77–87) 78 (73–83) 78 (73–83) 78 (73–83) 86 (82–90) 1.77 (0.18)
Excision margins 74 (69–80) 83 (78–87) 86 (82–90) 84 (80–89) 86 (82–90) 11.22 (0.001)
Vessel invasion 49 (43–55) 56 (50–62) 51 (46–57) 57 (51–63) 66 (61–71) 14.45 (0.001)
Presence of DCIS 74 (69–80) 77 (72–82) 74 (69–80) 73 (68–79) 77 (73–82) 0.17 (0.68)
Changes in 56 (50–62) 56 (50–62) 65 (59–71) 66 (60–72) 57 (51–62) 1.04 (0.31)
adjacent non-neoplastic
tissue
1The Mantel–Haenszel test for trend with 1 degree of freedom. CI, confidence interval; DCIS, ductal carcinoma in situ.each of the four items – histological type, size, grade and clearance
of the margins – widely regarded as the key to informed patient
management (Nakhleh et al, 1997) and vital for prognosis (Elston
and Ellis, 1991; Henson et al, 1991; Wijetunga et al, 1996). Only
28%, however, had reports which gave all the Pathology Working
Party’s recommended items of information. The deficiencies in
individual items such as tumour size (missing for 6% of women),
clearance of the margins (missing for 13%) and histological grade
(missing for 16%) gave cause for concern.
Compared with earlier Australian audits (Table 5), 1995
pathology reports were much more complete, particularly for
histological grade (+15 percentage points), excision margins (+10
percentage points) and DCIS (as much as +36 percentage points).
Completeness of reporting of tumour size, in comparison,
appeared to have reached a plateau, with little change (+1
percentage point) from 1992 after a larger improvement (+10
percentage points) from 1989 (Table 5).
Reporting of DCIS was relatively poor. Although most reports
gave architechture and three-quarters stated whether margins were
involved or clear, less than half gave size, nuclear grade or pres-
ence or absence of necrosis, suggesting a lack of a uniform
approach to histological reporting of these tumours. A 1995 survey
of specialist clinicians, mainly in the USA but including a handful
in Australia, ranked size and margin status (99–100% of surgeons
and oncologists), tumour architecture (93–98%) and nuclear grade
(88–94%) as the most desired information for clinical management
of DCIS (Nakhleh et al, 1997).
The ACN’s Pathology Working Party recommended that all
invasive carcinomas have ‘the Elston modification of Bloom and
Richardson’s grading … applied’ (ACN Pathology Working Party,
1997). The differences in completeness of reporting grade between
ductal (91% graded), lobular (34%) and other carcinomas (55%)
suggests that the grading of other than ductal carcinomas may
be a relatively new approach in Australian laboratories.
Relative newness may also account for the incompleteness of
DCIS reporting when it is present alone and as a component
of infiltrating ductal carcinomas NOS. Reports with breast cancer
size more often stated grade than those without. This coincidence
may suggest that when standard procedures include assessment of
one of these features, routine assessment of the other is also likely.
Pathology reports of invasive breast cancers in 1995 in Australia
had higher levels of information of size (complete for 94% of
women) and histological grade (84%) than a UK health region in
1992 (size and grade each 74% complete; Ma et al, 1997). The UK
study, on the other hand, had more complete information (94%) on
surgical margins of excision than in Australia (84%; Ma et al,
1997).
We found some evidence that completeness of reporting varied
with reporting volume particularly for laboratories rather than
individual pathologists. Reporting of cancer size, margins of exci-
sion and vessel invasion all increased significantly with laboratory
reporting volume. A similar trend was found in the 1992 audit in
NSW in which reporting was more complete from pathologists
who issued at least 2–3 reports a month or were based in teaching
hospitals (Bilous et al, 1995). Volume of institutional reporting in
the UK was also associated with item completeness, although
inconsistently since reporting of tumour size fell as volume
increased while margins of excision and histological grade were
more completely reported as volume increased (Ma et al, 1997).
Many pathologists, in assessing breast cancers, would have
carried out appropriate procedures (Rippey, 1996; Bull et al,
1997). Failure to state key information in pathology reports has
been attributed to inadvertant omission (Bull et al, 1997), the
tendency to substitute telephone consultation for completeness in
reporting (Miller and Slater, 1996; Hammond and Flinner, 1997),
perceptions of clinicians’ information needs (Nakhleh et al, 1997)
and significant uncertainty about best practice because of changing
knowledge of the importance of items for choices about manage-
ment and prognosis (Bull et al, 1997).
There was important variation among Australian states in
completeness of reporting of margins of excision, vessel invasion
and changes in adjacent tissue. Although margins of excision and
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Table 5 Completeness of pathology reporting in studies in Australia and the UK
Complete items in pathology reports for breast cancer cases
Key Item Australia 1995 UK 19921 NSW 19922 NSW 1986–19943 WA 19894
%% %% %
Tumour type 94 99 97
Tumour size 94 74 93 46 84
Margins of excision 87 94 77 60
Histological grade 84 84 69 47 45
Presence of DCIS 79 43
Adjacent non-neoplastic tissue 68
Changes in non-involved breast tissue 60
(NSW)
Vessel invasion 61
Lymphatic invasion 34 21
Vascular invasion 24 9 27
Axillary surgery mentioned 97 87
number of nodes involved 88 100 98 99
1Ma M, Bell J, Campbell S et al (1997) Breast cancer management: is volume related to quality? Br J Cancer 75: 1652–1659. 2Bilous M, McCredie M, Porter L
(1995) Adequacy of histopathology reports for breast cancer in NSW. Pathology 27: 306–311. 3Wijetunga LHR, Carmalt HL, Gillett DJ (1996) A review of
pathology reporting for breast cancer. Aust NZ J Surg 66: 723–726. 4Harvey JM, Sterrett GF, Parsons RW et al (1995) Breast cancer in Western Australia in
1989: IV. Summary of histopathological assessment in 655 cases. Pathology 27: 12–17.vessel invasion were increasingly completely reported as volume
of reporting in laboratories increased, three States had consistently
low levels of information. A strong State-level influence was
suggested by the observation that one State had the lowest levels
of reporting on all items other than tumour type (Table 1). We do
not know the reason for this difference between States.
The change from more to less radical surgical procedures has
meant that pathology information is not only important in giving a
prognosis and deciding on post-operative adjuvant therapy for the
woman with breast cancer, but is also important for monitoring the
quality of health care. Measurement of quality in surgery, by
auditing surgical margins and the numbers of nodes excised, and
the performance of early detection programmes by monitoring
size, grade and nodal status rely on pathology information. Given
the higher incidence of DCIS since the introduction of mammo-
graphic screening, it is important also that reporting of the
pathology of these cancers is more uniform and of high quality.
Use of a standard form or checklist is the one practice found to
be significantly associated with an increased completeness of
reporting of selected items in pathology reports of cancer (Zarbo,
1992; Bilous et al, 1995; Wijetunga et al, 1996; Rippey, 1996;
Shepherd and Quirke, 1997; Bull et al 1997). Synoptic reporting
was recommended by the ACN’s Pathology Working Party and
its widespread adoption would be expected to lead to further
increases in completeness of reporting. These increases would, in
turn, be expected to lead to improved outcomes and quality of
care. One option to increase the use of synoptic reporting in
Australia might be to consider its adoption as an accreditation
requirement for pathologists and laboratories.
By measuring completeness of item information, we have
undertaken the first steps in ascertaining the quality of pathology
reporting. We believe that this simple process has highlighted
important gaps in reporting breast cancers in Australia in 1995. We
have circulated a summary of audit outcomes to all members of
the Royal College of Pathologists Australia and the complete
report to major health organizations. Passive, dissemination-only
strategies, however, are known to be generally ineffective in
improving practice (Bero et al, 1998). While more intensive,
‘multifaceted’ strategies that combine methods, such as locally-
based consensus processes and participation in audit with feed-
back, would probably be more effective with pathologists and
laboratories (Bero et al, 1998), our audit was designed to assess
performance at a national or state, and not an individual, level. A
much larger sample size would be needed to obtain sufficiently
precise estimates of individual performance that could be supplied
as individual feedback.
The existence of the ACN’s recommendations speaks to a local
consensus on the value of key items in breast cancer care. What is
needed is a mechanism to assist laboratories and individuals to
implement more uniform reporting standards (Bull et al, 1997;
Shepherd and Quirke, 1997; Nakhleh et al, 1997). Research
evidence suggests that consistently effective interventions for
change in health professionals are multifaceted, flexible, system-
atized, focussed on everyday practice and locally based, and
include self-assessment and feedback, practice reminders,
consensus processes and interactive educational meetings (du
Boulay, 1997; Bero et al, 1998). Currently, no one organization has
a mandate to ensure that research findings about pathology
reporting standards and interventions to improve professional
performance are translated into improvements in everyday
practice.
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